Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Baraldo, L. Pinton, A. Ballarin, S. Mandruzzato, E. Bazzan, E. Falisi, G. Turato, K. Lokar-Oliani, M. Cosio, P. Zanovello, M. Saetta (Padova, Italy; Montreal, Canada). Myeloid derived suppressor cells in the crosstalk between COPD and lung cancer. Eur Respir J 2011; 38: Suppl. 55, 3851

Member's Comments

No comment yet.

Related content which might interest you: Intersections of lung progenitor cells, lung disease and lung cancer Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017 Year: 2017 Myeloid derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in COPD Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Regulatory mechanims of ER-ß of OPN-Integrin interaction in the migration of human lung cancer cells Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Epithelial cell matrix proteins and lymphocyte activation genes in COPD and lung cancer Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer? Source: International Congress 2016 – Mechanisms of disease Year: 2016 Lung stem cells and lung cancer Source: ERS Lung Science Conference 2017 Year: 2017 Exploration of the evidence of cancer stem cells in lung cancer Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Circulating CD133(+) stem cells in lung cancer patients Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Fibrosis-specific stem-like cells in peripheral IPF lung: Characteristics and potential role Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 The emerging role of myeloid-derived suppressor cells in lung diseases Source: Eur Respir J 2016; 47: 967-977 Year: 2016 Stem cells and lung cancer Source: Eur Respir Monogr 2021; 91: 340-352 Year: 2021 CD33+CD14-CD11b+CD66b+CD15+VEGFR-1hi myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features Source: International Congress 2016 – Lung cancer immunology: latest research Year: 2016 CHD4 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor cell proliferation Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Cytokine network in relation to regulatory cells in lung cancer microenvironment Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Ghrelin does not influence cancer progression in a lung cancer cell line and mice with lung adenocarcinoma Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015 Over-expression of aquaporin-5 increases migration and metastatic potential of lung cancer cells Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005